Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs

The aim of this study was to investigate the association between body-mass index (BMI) and remission in RA patients receiving conventional synthetic (cs-) or the biological Disease-Modifying Antirheumatic Drug (DMARD), tocilizumab. Individual participant data (IPD) were pooled from five trials inves...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scientific reports 2020-10, Vol.10 (1), p.18634, Article 18634
Hauptverfasser:	Abuhelwa, Ahmad Y., Hopkins, Ashley M., Sorich, Michael J., Proudman, Susanna, Foster, David J. R., Wiese, Michael D.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4023 692/4023/1670 692/4023/1670/498 692/53/2422 Adult Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Body Mass Index Body weight Clinical trials Cohort Studies Female Heterogeneity Humanities and Social Sciences Humans Male Methotrexate Middle Aged multidisciplinary Obesity Obesity - complications Overweight Proportional Hazards Models Remission Remission (Medicine) Remission Induction Rheumatoid arthritis Science Science (multidisciplinary) Underweight
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!